Exploration on the rule of syndrome differentiation and treatment and medication of coronary heart disease based on medical record study about Chinese medical master #br#
YU Fan1 HAN Aiqing2 ZHOU Xuezhong3 LI Ping1 WANG Haolin2
1.Department of Cardiology, the Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing 100029, China;
2.School of Management, Beijing University of Chinese Medicine, Beijing 100029, China;
3.School of Computer and Information Technology, Beijing Jiaotong University, Beijing 100044, China
Abstract：Objective To discuss the rule of syndrome differentiation and treatment and medication strategy of coronary heart disease by Chinese medical master. Methods The medical records of Chinese medical masters were collected from published literatures and monographs by literature research method. The retrieval sources of documents and monographs were China national knowledge internet, Wanfang data knowledge service platform, Chongqing VIP Chinese periodical database, National Library of China·China National Digital Library and National Library Reference Alliance. The retrieval time was from the establishment of the database to January 2021. The collected medical record information was used for statistical analysis and data mining. Results A total of 190 research articles and 38 monographs were included, and 278 medical records were collected. A total of 17 high-frequency four diagnosis information, 13 high-frequency syndrome information, 8 high-frequency treatment methods, 21 high-frequency drugs and 15 high-frequency drug pairs were obtained. Conclusion Medical records of Chinese medical masters suggest that the location of coronary heart disease is in the heart, which is closely related to liver, spleen, and kidney. Blood stasis and phlegm are the core syndrome, and a variety of syndromes coexist. The treatment takes promoting blood circulation as the core, combined with a variety of treatment methods. Drug use has an obvious concentration trend, and drug compatibility mostly comes from classical prescriptions.
余帆1 韩爱庆2 周雪忠3 李平1 王浩霖2. 基于医案研究的国医大师冠心病辨治规律与用药探索[J]. 中国医药导报, 2022, 19(13): 115-118.
YU Fan1 HAN Aiqing2 ZHOU Xuezhong3 LI Ping1 WANG Haolin2. Exploration on the rule of syndrome differentiation and treatment and medication of coronary heart disease based on medical record study about Chinese medical master #br#. 中国医药导报, 2022, 19(13): 115-118.
京公网安备 11010502046598号